English
Deutsch
Español
Français
Polski
Português
Română
Русский
繁體中文

Stem Cell Treatment for Optic Nerve Atrophy (ONA)

A combination of stem cells and extensive therapies giving the patient real chances of improvement

How does stem cell therapy for ONA work?

Since 2007, we have been developing comprehensive stem cell treatment protocols for optic nerve atrophy (ONA) to overcome the limitations of conventional therapies.

In our protocols, stem cells are combined with specialized therapies for ONA that not only focus on helping the patient to cope with their symptoms, but also treat the root cause of the condition by promoting the healing of the optic nerve. We believe that our comprehensive treatment approach for ONA gives our patients the best chances for vision improvement, allowing for a better quality of life. 

Repair optic nerve atrophy using stem cells

The optic nerve acts as a signal transmission channel between the retina in the eye and the visual cortex in brain. When the optic nerve is damaged (atrophy), visual signals become unable to travel freely to the brain and the patient gets affected by partial or total loss of vision.

It is important to remember that optic nerve atrophy can arise from various demyelinating, inflammatory, ischemic or traumatic origins, and conditions such as open angle glaucoma, optic neuritis or Leber hereditary optic neuropathy are among the various causes of ONA. In some cases, the optic nerve atrophy is causing a constant and progressive loss of vision.   

Few conventional treatment options are available for patients diagnosed with ONA, which mostly focus on helping the patients to cope with their disability. However, none of them are actually treating the loss of optic nerve function. Stem cells have the ability to regenerate nerve cells in the optic nerve, allowing ONA patients to recover some vision.  

Possible improvements after Stem Cell Therapy for Optic Nerve Atrophy

The purpose of our stem cell treatment is to restore neurological function in the lesion area and repairing nerve damage on the optic nerve. Various kinds of improvement are possible after our treatment and our past patients have experienced the following*:

  • Sharpened visual acuity
  • Enhanced light perception
  • Enlarged visual field
  • Brighter night vision
  • Reduced nystagmus
  • Improved strabismus

*It is important to remember that as for any medical treatment, improvements cannot be guaranteed. Please contact us for more information regarding the possible improvements for a particular case.

Our Treatment Program in Details

We have been developing and optimizing our stem cell treatment protocols with the concept that only a very comprehensive solution can allow our patients to truly benefit from stem cells. We believe that stimulation through various therapies is necessary to enhance stem cell regenerative response. We provide a wide variety and large quantities of stem cells in order to adapt to each patient specific condition and deliver maximized regenerative potential.

Our stem cell treatment for Optic Nerve Atrophy (ONA) consist in 6 to 8 simple and minimally invasive injections of umbilical cord derived stem cells. The stem cells are transplanted using two or three different methods: intravenous via a standard IV drip, through intrathecal injection. Patients older than 10 years old may also receive two retrobulbar injections to better target the optic nerves.* Together, these 3 injection methods allow for increased efficacy while ensuring safety and minimum inconvenience for the patient.

*Not all patients can receive a retrobulbar injection. The acting doctor will decide If it is possible.

  • 15 to 23 Days Stay
  • IV, Intrathecal and Retrobulbar Injections
  • UCBSC / UCMSC Cells
  • Daily Therapy Program
  • 120-400 Million Cells
  • Nutrition Program

Patient Experience Stories

Find out more about patients previously treated with Beike stem cell protocols. The families participating in these blog posts talk about their stories and present their own view of the treatment, including thoughts regarding the daily therapies, the stem cell injection themselves as well as improvement noticed during and after treatment.

Open letter from a patient’s mom

Sophie’s mom wrote us feedback in the form of a letter and with her consent, we decided to share it with you below… Sophie was born with Optic Nerve Hypoplasia, a rare genetic deficiency. She was diagnosed with chronic non-progressive encephalopathy, also known as cerebral palsy, when she was three …

Stem Cell Treatment for Pigmentary Retinopathy Patient Experience

Romanian patient Ovidiu Simion was diagnosed with pigmentary retinopathy, a condition which accelerates the degeneration of the visual field. Patients with this condition experience increasing loss of vision and may feel as if they are looking through a telescope due to the limited range of vision. Below is a brief …

Yoga Instructor Kevin Naidoo Discusses Vision Improvements After Stem Cell Treatment [Video]

Kevin Naidoo, a yoga instructor from Saskatoon, Canada recently returned home from his stem cell treatment “adventure” in Bangkok, Thailand to treat his Optic Nerve Atrophy (ONA) which was caused by Glaucoma, which is an increase of intra-ocular pressure that can damage the optic nerve. His treatment utilized adult stem …

Stem Cell Quality and Quantity Ensured

Packaging for Beike Biotechnology Stem Cell products

Different types of stem cells for different needs

Beike provides stem cells from two separate sources: umbilical cord blood and umbilical cord tissue. Umbilical cord related samples are donated by healthy mothers after normal births and are sent to Beike Biotech’s laboratories for processing.

After reviewing the patient’s full medical information, our doctors will recommend which source of stem cells should be used for treatment. Our treatment protocols may include one or multiple types of stem cells in combination depending on each patient’s specific condition.

Highest International Stem Cell Processing Standards

Beike Biotechnology is processing its own adult stem cells in its internationally accredited laboratories. The company has full control over the processing and quality control of all stem cell products, ensuring perfect safety and highest quality.

Stammzellenbehandlungen Doktor

Patient Videos

Below are video interviews recorded during treatment with Beike stem cells. The families showcased in these videos talk about their personal stories and their experience of the treatment including the improvement noticed.

The improvements mentioned in these videos are typical, however it does not guarantee that all patients may have the same improvements.

Why Choose Beike for a Stem Cell Treatment?

Experience: With more than a decade of practice, you are ensured to be advised and treated by competent professionals.

Safety: Accredited by the American Association of Blood Banks (AABB) and following highest international standards, our stem cell processing methods and laboratories ensure that you receive the best stem cell quality available.

Diversity: Multiple types of stem cells having different capabilities are available to adapt to each patient’s specific condition. We do not use the same type of stem cells for all patients.

Extensiveness: A complete supportive therapy program is provided daily to stimulate patient’s freshly transplanted stem cells. The best improvement can only be obtain by supporting your stem cells.

Support: A full follow-up program is provided after the treatment and you will be asked to take part in it at 1, 3, 6 and 12 months after treatment. Access to our team after the treatment is very important as you may receive further advice to maximize improvements.

Beike-Biotechnology head office building located in Shenzhen China

Founded in July 2005, Shenzhen Beike Biotechnology is a national high-tech enterprise specialized in clinical transformation and technical service of biological treatment technology of strategic emerging industries.

Get more information now


Frequently asked questions about ONH/SOD

References

  1. Rubens Camargo SiqueiraI; Júlio Cesar Voltarelli; André Marcio Vieira Messias; Rodrigo Jorge. Possible mechanisms of retinal function recovery with the use of cell therapy with bone marrow-derived stem cells.
  2. Tantai Zhao & Yunqin Li & Luosheng Tang et al. Protective effects of human umbilical cord blood stem cell intravitreal transplantation against optic nerve injury in rats. Graefes Arch Clin Exp Ophthalmol DOI 10.1007/s00417-011-1635-7.
  3. Yiming Huang & Volker Enzmann & Suzanne T. Ildstad. Stem Cell-Based Therapeutic Applications in Retinal Degenerative Diseases. Stem Cell Rev and RepDOI 10.1007/s12015-010-9192-8.
  4. Pinilla I, Martin Nieto J, Cuenca N. Stem Cell Potential Uses in Retinal Dystrophies. Arch Sic Esp Oftalmol 2007; 82: 127-128.
  5. Paul S. Baker and Gary C. Brown. Stem-cell therapy in retinal disease. Current Opinion in Ophthalmology 2009, 20:175–181.
  6. Isabel Zwart, Andrew J. Hill, Faisal Al-Allaf et al. Umbilical cord blood mesenchymal stromal cells are neuroprotective and promote regeneration in a rat optic tract model. Experimental Neurology 216 (2009) 439–448.
  7. Annegret Dahlmann-Noon et al. Current approaches and future prospects for stem cell rescue and regeration of retina and optic nerve. can J Ophthalmol 2010;45:333-41.
  8. Naoko Koike Kiriyama et al. Human cord blood stem cells can differentiate into retinal nerve cells. Acta Neurobiol Exp 2007, 67;359-365.